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Peptic ulcers are an important pathology, and the search for safer and more effective treatment methods is 
of paramount importance. In this study, we assess the gastroprotective effects of the hydroethanolic extract 
(HE) and ethyl acetate fraction (EAF) from Kalanchoe pinnata leaves against an ethanol/HCl-induced 
ulcer model in rats. The HE reduced gastric lesions by approximately 47% (400 mg/kg). A significant 
inhibition of the gastric lesions by 50% was observed after pretreatment with the EAF (200 mg/kg). 
Quercetrin and quercetin 3-O-α-L-arabinopyranosyl-(1→2)-α-L-rhamnopyranoside were isolated and 
identified in the flavonoid fraction (EAF) by HPLC and NMR analyses because this fraction showed 
the highest gastroprotective effect. This fraction demonstrated high antioxidant activities (CE50=41.91 
µg/mL) by DPPH in comparison with Trolox® and 11.33 mmol Trolox® equivalent by ORAC. In 
conclusion, the HE and FAE from K. pinnata displayed gastroprotective activity in rats, most likely due 
to the presence of flavonoids.
Uniterms: Gastric ulcer/study/rats. Gastric ulcer/treatment. Kalanchoe pinnata/chromatographic profile. 
Kalanchoe pinnata/gastroprotective activity. Quercetrin. Quercetin 3-O-α-L-arabinopyranosyl-(1→2)-
α-L-rhamnopyranoside.
INTRODUCTION
For the past two centuries, peptic ulcers have caused 
high morbidity and mortality (Malfertheiner, Chan, 
Mccoll, 2009). This disease is a serious and prevalent 
pathology (Calam, Baron, 2001). A peptic ulcer is a 
chronic lesion, usually single, that can be located in the 
gastric or duodenal mucosae (Kumar, Abbas, Fausto, 
2005). In the UK, the incidence of this disease was 12% 
higher in men than in women (Araujo, Borini, Guimarães, 
2014). A review article (January 1980 to February 2009) 
showed that the incidence rate of uncomplicated peptic 
ulcers was approximately one case per 1000 people per 
year in the general population; the incidence rate for 
complicated peptic ulcers that included bleeding and 
perforation was approximately 0.7 cases per 1000 people 
per year (Lin, Rodrígues, Hernándes-Diaz, 2011).
The pathophysiology of peptic ulcers suggests that this 
disease is caused by an imbalance between defensive factors 
(mucus and bicarbonate secretion, mucosal barrier, blood 
flow, and prostaglandins) and destructive factors (reactive 
oxygen species and acid and pepsin secretion), resulting 
in the acute inflammation of the gastrointestinal mucosae 
(Laine, Takeuchi, Tarnawski, 2008). Several stimuli serve 
as offensive factors, including Helicobacter pylori, the 
use of nonsteroidal anti-inflammatory drugs (NSAIDs), 
stress, alcohol and cigarette smoking (Malfertheiner, 
Chan, Mccoll, 2009; Malnick et al., 2014). The current 
medical treatment for peptic ulcers is generally based on 
proton pump inhibitors and histamine H2-receptor blockers 
(Jain et al., 2007). However, the long-term use of these 
therapeutic agents can produce adverse effects, such as 
hypergastrinemia and hyperplasia in the enterochromaffin-
like (ECL) cells, the risk of pneumonia, diarrhea and the 
disturbance of human gastrointestinal microflora (Orlando, 
Lenard, Orlando, 2007; Bays, Finch, 1990; Devault, Talley, 
2009; Ksiadzyna, Szelag, Paradowski, 2015). Therefore, 
the search for safer and more effective alternatives to treat 
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gastric ulcers is of paramount importance. Medicinal 
plants are considered an excellent alternative and have 
been used to cure ailments for centuries (Zhang et 
al., 2015). Many studies have reported that medicinal 
plants and the compounds isolated from them, such as 
flavonoids, have gastroprotective activities (Awaad, El-
Meligy, Soliman, 2013). Unfortunately, there is a lack 
of complete information regarding the pharmacokinetic 
factors (absorption, distribution, metabolism and 
elimination) and pharmacodynamic factors of medicinal 
plants (Mancuso, 2015). Herbal medicines include many 
bioactive compounds that can modify drug disposition. 
One example is the possibility of interactions with drug 
metabolizing enzymes, such as isoforms of cytochrome 
P450 (CYP) and UDP-glucuronosyltransferase (UGT) 
and sulfotransferases (SULT) or transporters (Brantley 
et al, 2014), leading to the possibility of side-effects, 
mainly when co-administered with another medication. 
Polyphenolic compounds are often found in natural 
products. Their metabolism is mediated by (UGT) in the 
intestine and liver. The inhibition of UGTs in the intestine, 
which is the first barrier to oral xenobiotics, by these 
compounds could alter drug disposition (Roe et al., 2016). 
Therefore, medical supervision is important because the 
overuse of herbal medicines can possibly pose health risks 
(Mancuso, 2015).
Kalanchoe pinnata  (Lam.) Pers. (synonym: 
Bryophyllum pinnatum) (The Plant List, 2015) is a 
perennial herb. This species is popularly known in Brazil 
as “folha-da-fortuna,” “coirama,” “courama,” “courama-
vermelha,” and “saião roxo”. In Brazil and other parts of 
the world, it is widely used to treat diarrhea and vomiting, 
earache, gastric ulcers, burns, abscesses, and insect bites 
(Almeida et al., 2000; Afzal et al., 2012). The leaves of 
this plant are reported to possess wound healing (Nayak, 
Marshall, Isitor, 2010), anti-inflammatory (Ferreira et al., 
2014), antioxidant (Hazarika et al., 2012), antimicrobial 
(El Abdellaoui et al., 2010) and antileishmanial properties 
(Muzitano et al., 2006a). Pal, Chaudhuri (1991), 
Adesanwo et al., (2007); Braz, Oliveira, Viana (2013) have 
reported the antiulcer activity of the methanolic fraction 
and the methanol and aqueous extract of K. pinnata. 
Phytochemical investigations have shown the presence 
of tannins, alkaloids and saponins (Biswas et al., 2011), 
bufadienolides (Yamagishi et al., 1989) and, mainly, 
flavonoids (Fürer et al., 2013) in K. pinnata. 
In this study, we demonstrate the gastroprotective 
effect of the hydroethanolic extract and the ethyl acetate 
fraction from the leaves of Kalanchoe pinnata against 
ethanol-acidified gastric ulcer in rats. In parallel with 
the pharmacological study, a chemical analysis was 
performed; flavonoids were shown to be the main 
compounds in the fraction. 
MATERIAL AND METHODS
Plant material
The leaves of Kalanchoe pinnata (Lam.) Pers. 
Crassulaceae were collected at the Chemical, Biological 
and Agricultural Pluridisciplinary Research Center-
Campinas State University (CPQBA-UNICAMP), 
Paulínia, São Paulo, Brazil. A voucher specimen was 
deposited at Collection of Medicinal and Aromatic Plants 
(CQBA-UNICAMP) under the number 337. 
Extract preparation
The fresh leaves were cut into small pieces and dried 
at 40 ºC. The ethanol:water (7:3) extract was prepared by 
maceration for 7 days. The extract was concentrated under 
reduced pressure and then lyophilized. The hydroethanolic 
extract was partitioned using chloroform, ethyl acetate 
and water. 
HPLC analysis and identification of the 
compounds
Briefly, the separation of the ethyl acetate fraction 
was performed in a Shimadzu® model LC-20 AT 
instrument with a diode array detector (DAD). The 
separation was carried out on a 250 mm x 4.6 mm, 5 
µm Shim-pack VP-ODS C18 reverse-phase column 
(Shimadzu®). HPLC-grade acetonitrile (solvent B) and 
purified water with 0.1% trifluoroacetic acid (solvent A) 
were used as the mobile phase. The gradient program used 
was as follows: (1) 5% solvent B for 0-5 min and then (2) 
5-100% solvent B for 60 min. The flow rate was 1 mL/min, 
20 μL samples (1 mg/mL) were injected, and the detection 
occurred at 254 nm. The isolation of the major constituents 
was achieved on an HPLC semi-preparative UV system 
(Shimadzu® - C18 Shim-pack PREP-ODS 250 mm x 
20 mm, 5 µm, flow rate 10 mL/min). The mobile phase 
consisted of 25% acetonitrile and water with 0.1% 
trifluoroacetic acid, and the detection occurred at 254 nm. 
The major compounds were identified by 1H and 13C NMR 
spectra on a Bruker Avance DRX-300 (1H: 300 MHz; 13C: 
75 MHz) using CD3OD as the solvent. 
Total flavonoid content
Flavonoids were quantified using the adapted 
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methodology of Noriega et al. (2012). Twenty microliters 
of hydroethanolic extract and ethyl acetate fraction from 
the K. pinnata leaves in 60% ethanol were added to 20 
µL of 2% AlCl3 in a 96-well microplate. A sixty percent 
ethanol solution was added to bring the volume to 250 µL. 
Quercetin was used as a standard for the calibration curve. 
The absorbance was measured after 30 min at 430 nm in a 
Synergy™ HT Multi-Detection Microplate Reader. All the 
analyses were performed in triplicate, and the results were 
expressed as a quercetin equivalent (mg of quercetin/g of 
dry weight of test sample). 
Total phenolic content
The total phenolic content was determined using 
the Folin Ciocalteu method adapted from Ainsworth; 
Gillepsie (2007). In a 96-well microplate, 20 µL of the 
hydroethanolic extract, ethyl acetate and aqueous fractions 
from the K. pinnata leaves were mixed with 50 µL of 
Folin-Ciocalteu reagent and 100 µL of saturated sodium 
carbonate (700 mM). After two hours, in the absence 
of light, the absorbance was measured at 765 nm using 
a Synergy™ HT Multi-Detection Microplate Reader. 
Gallic acid was used for the calibration curve. All the 
analyses were performed in triplicate, and the results were 
expressed as gallic equivalent (mg of gallic acid/g of dry 
weight of test sample).
Antioxidant activity
The scavenging activity of the hydroethanolic extract 
and ethyl acetate fraction was assessed using the 2,2-diphenyl-
1-picrylhydrazyl (DPPH.) radical (Brand-Williams, Cuvelier, 
Berset, 1995). Briefly, 50 µL of the samples, Trolox® 
(standard compound) at varying concentrations and 150 
µL of DPPH (175 μM) were added to a 96-well microplate. 
The samples, Trolox® and DPPH were solubilized in 80% 
methanol. A control solution, without a test sample, was 
prepared with DPPH solution and 80% methanol. All the 
analyses were completed in triplicate. After 2 hours of 
reaction with absence of light, the absorbance was measured 
in a Synergy™ HT Multi-Detection Microplate Reader at 517 
nm. The ability to scavenge the DPPH radical was calculated 
using the following equation:
DPPH∙ Scavenging effect (%) = [(Absc – Absa) / Absc] × 100
where Absc is the absorbance of the control reaction, and 
Absa is the absorbance of the sample or Trolox®. 
The Ec50 value was calculated as the concentration of 
the sample required to scavenge the DPPH radical by 50%.
The ORAC (Oxygen Radical Absorbance Capacity) 
assay was carried out using an automated microplate 
reader. Filters were selected for an excitation wavelength 
of 485 nm and an emission wavelength of 515 nm. In 
addition, AAPH was used as a peroxyl radical generator, 
Trolox® as a standard, and fluorescein as a fluorescent 
probe. In 96-well microtiter plates, twenty-five microliters 
of hydroethanolic extract (10 mg/mL), ethyl acetate 
fraction (10 mg/mL) from K. pinnata, blank or Trolox® 
calibration solution (6.25 to 100 μM) were mixed with 150 
μL of fluorescein (40 nM) and incubated for 15 min at 37 
°C before injecting 25 μL of the AAPH solution (173 mM). 
The fluorescence was measured every minute for 1 h. The 
final ORAC values were calculated using the net area 
under the decay curves. The results were expressed as 
mmol of Trolox® equivalent (TE)/g of dry weight of the 
test sample (Prior et al., 2003).
In vivo assays
Animals
Male Wistar rats (150 to 180 g) from the Central 
Animal House of the School of Pharmaceutical Sciences 
and the Chemistry Institute of the University of São Paulo 
were used. The animals were kept under the following 
standard conditions: (1) food and water ad libitum, (2) 12 
h dark-12 h light, (3) temperature of 22 ± 2 ºC, and (4) 55 
± 10% humidity. The samples (hydroethanolic extract and 
ethyl acetate fraction), cloprostenol (standard drug) and 
water (used as the vehicle) were administered by gavage. 
The Commission of Ethics in Animal Experimentation of 
FCF-USP approved all the procedures under number 426.
Ethanol/HCl-induced ulcer model
The procedure was performed according to the 
method described by Mizui; Doteuchi (1983). The rats 
were fasted for 12 hours and were kept in cages with raised 
floors of wide mesh to prevent coprophagy. The animals 
were divided into the following five treatment groups: (1) 
vehicle (water 10 mL/kg b.w.), (2) cloprostenol (150 μg/
kg) (Neughebauer et al., 1992), (3) hydroethanolic extract 
(100, 200 and 400 mg/kg) and (4) ethyl acetate fraction 
(50, 100 and 200 mg/kg). Following 30 minutes of oral 
treatment with the above samples, the gastric lesions were 
induced with 300 mmol/L HCl in 60% ethanol (10 mL/kg). 
One hour later, the animals were sacrificed, and the stomachs 
were removed and opened along the greater curvature. The 
injuries were analyzed using Image Pro-Plus® software, 
and a relative lesion area was determined (RLA in %). 
The relative lesion area was determined as follows: 
F. Sobreira, L. S. Hernandes, A. Vetore-Neto, I. E. C. Díaz, F. C. Santana, J. Mancini-Filho, E. M. Bacchi
Braz. J. Pharm. Sci. 2017;53(1):e16027Page 4 / 11
RLA = (TLA x 100)/TA, where TLA= total lesion area 
(mm2), and TA= total stomach area (mm2).
Statistical analysis
The values were transformed using the square root 
method to normalize the data distribution. The results 
were expressed as the mean ± S.E.M. and analyzed by one-
way ANOVA followed by Dunnett’s post-hoc test using 
GraphPad Prism 5 software. The results were considered 
statistically significant when the p-value was less than 0.05.
RESULTS/DISCUSSION
The ethanol/HCl-induced ulcer model is a well-
established method for the evaluation of gastroprotective 
effects. Ethanol produces an inflammatory response, 
consequently destroying the stomach-protecting layers 
and provoking hemorrhagic ulceration of the stomach in 
experimental animals (Gazzieri et al., 2007; Castro et al., 
2010). Moreover, ethanol in contact with gastric mucosa 
produces oxygen free radicals (Pan et al., 2008). The role 
of HCl in the ethanol solution is to accelerate gastric ulcer 
formation (Mizui, Doteuchi, 1983). The gastroprotective 
effects of the hydroethanolic extract and ethyl acetate 
fraction from the leaves of Kalanchoe pinnata were 
assessed using this model.
The results obtained from the ethanol/HCl model 
showed that the hydroethanolic extract exerted 47% 
(p<0.01) protection on the gastric mucosa at a dose 
of 400 mg/kg (Figure 1). Pretreatment with the ethyl 
acetate fraction at 200 mg/kg dose significantly inhibited 
(p<0.001) gastric ulcers by 50% (Figure 2). For both 
experiments, cloprostenol, an analogue of PGF2 alpha, was 
used as a positive control because it is related to mucosal 
defense (Neughebauer et al., 1992). Prostaglandins can 
inhibit gastric acid secretion and stimulate mucus and 
bicarbonate secretion and mucosal blood flow to promote 
ulcer healing (Wallace, 2008). A previous study with 
methanolic extract (20 mg/kg and 40 mg/kg) in an ulcer 
model induced by indomethacin demonstrated inhibition 
indices of 49.39% and 71.08%, respectively (Adesanwo 
et al., 2007). In contrast to this study, other studies using 
an aqueous extract (1 g/kg and 2 g/kg) in an indomethacin 
model and a methanolic fraction (100 mg/kg and 300 mg/
kg) in an ulcer-induction ethanol model of leaves from 
K. pinnata showed the inhibition of gastric lesions by 
45.49% and 49.50% and 37.5% and 54.2%, respectively 
(Pal, Chaudhuri, 1991; Braz, Oliveira, Viana 2013). 
However, our results showed that the ethyl acetate fraction 
displayed superior antiulcer activity by 50% at a dose of 
200 mg/kg. Non-coincident results by different authors can 
be explained by the use of different extraction solvents. 
Studies reported that different methods of extraction and 
solvent systems used to extract bioactive compounds from 
medicinal plants are an important issue to consider because 
these factors have an influence on biological activities 
(Hayouni et al., 2007; Murugan, Parimelazhagan, 2014).
Chemical analyses were performed with the aim 
of isolating and identifying the major compounds in the 
ethyl acetate fraction because this sample showed the 
FIGURE 1 - Effect of the hydroethanolic extract from Kalanchoe 
pinnata leaves on the ethanol/HCl-induced gastric model in 
Wistar rats. Relative lesion area is presented as the mean ± S.E.M.; 
n=7 for each group. ANOVA was carried out and followed by 
Dunnett's test, ** p < 0.01; *** p < 0.001 compared to water. 
FIGURE 2 - Effect of the ethyl acetate fraction from Kalanchoe 
pinnata leaves on the ethanol/HCl-induced gastric model 
in Wistar rats. Relative lesion area is presented as the 
mean ± S.E.M.; n=7 for each group. ANOVA was carried out and 
followed by Dunnett's test, *** p < 0.001  compared to water. 
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best results in the antiulcer assay. This study, however, 
is the first to establish a relationship between the major 
compounds and their activity. Many studies have shown 
that flavonoids interact with gastric ulcers. Jung et al., 
(2007) reported that the flavonoid-rich fraction from 
Orostachys japonicus (Crassulaceae) reduced HCl/
ethanol-induced gastric lesions and that the anti-ulcer 
activity could be attributed to the flavonoid compounds. 
Batista et al., (2013) demonstrated that the flavonoid-rich 
fraction from Syngonanthus macrolepsis (Eriocaulaceae) 
at a dose of 100 mg/kg protected the gastric mucosa in 
animals, most likely due to the involvement of sulfhydryl 
compounds and the antioxidant system. 
In our study, the HPLC-DAD analysis (Figure 3) of 
the ethyl acetate fraction indicated two major compounds 
(1 and 2). These substances were isolated and identified by 
1H and 13C NMR (using CD3OD as the solvent).
Compound 1 (Figure 4) was identified as quercetin 
3-O-α-L-arabinopyranosyl-(1→2)-α-L-rhamnopyranoside 
by 1H NMR (300 MHz) and 13C NMR (75 MHz). 1H-NMR 
(CD3OD, 300 MHz) spectra showed peaks at δ 7.37 (d, J 
= 1.8 Hz, H-2’), 7.00 (dd, J = 8.4, 2.1 Hz, H-6’), 6.93 (d, J 
= 8.4 Hz, H-5’), 6.37 (d, J = 2.1 Hz, H-8), 6.21 (d, J = 2.1 
Hz, H-6), 5.38 (d, J = 0.9 Hz, H-1’’), 4.21 (d, J = 7.2 Hz, 
H-1’’’), 4.19 (m, H-2’’), 3.9 (m, H-3’’), 3.8 (m, H-5’’), 3.74 
(m, H-4’’’), 3.66 (dd, J = 12.9, 2.0 Hz, H-5’’’), 3.56 (dd, J = 
9.3, 7.2 Hz, H-2’’’), 3.47 (dd, J = 9.3, 3 Hz, H-3’’’), 3.39 (d, 
J = 11.4 Hz, H-5’’’), 3.35 (dd, J = 9.3, 9.3 Hz, H-4’’), and 
1.02 (d, J = 6.3 Hz, H-6’’). 13C-NMR (CD3OD, 75 MHz) 
showed peaks at δ 179.85 (C-4), 165.86 (C-7), 163.25 
(C-9), 159.21 (C-5), 158.55 (C-2), 149.86 (C-4’), 146.52 
(C-3’), 136.88 (C-3), 122.99 (C-1’), 122.77 (C-6’), 116.91 
(C-2’), 116.55 (C-5’), 107.83 (C-1’’’), 105.91 (C-10), 
103.28 (C-1’’), 99.88 (C-6), 94.81 (C-8), 82.72 (C-2’’), 
74.37 (C-4’’), 73.84 (C-3’’’), 72.86 (C-2’’’), 72.06 (C-5’’), 
71.82 (C-3’’), 69.90 (C-4’’’), 67.47 (C-5’’’), and 17.76 (C-
6’’). Our results were compared and were consistent with 
the results presented by Muzitano et al. (2006a), who also 
reported that quercetin 3-O-α-L-arabinopyranosyl-(1→2)-
α-L-rhamnopyranoside may be a chemical marker for K. 
pinnata because it is not common in other plant species, 
except for Alphitonia philippinensis (Rhamnaceae) and 
Rollinia emarginata (Annonaceae) (Jou et al., 2004; Roth 
et al., 2011). 
Compound 2 (Figure 4) was identified as quercitrin. 
Our results were compared and found to be consistent 
with those described by Hanamura; Hagiwara; Kawagishi 
(2005) [47]. 1H-NMR (CD3OD, 300 MHz) spectra showed 
peaks at δ 7.35 (d, J = 1.7 Hz, H-2’), 7.30 (dd, J = 8.3, 1.8 
Hz, H-6’), 6.92 (d, J = 8.3 Hz, H-5’), 6.35 (d, J = 1.7 Hz, 
H-8), 6.19 (d, J = 1.5 Hz, H-6), 5.36 (s, H-1’’), 4.25 (s br, 
H-2’’), 3.78 (dd, J = 9, 3.2 Hz, H-3’’), 3.43 (dd, J = 9.6, 6 
Hz, H-5’’), 3.35 (t, J = 9 Hz, H-4’’), and 0.95 (d, J = 6.4 
Hz, H-6’’). 13C-NMR (CD3OD, 75 MHz) showed peaks at 
δ 179.68 (C-4), 165.82 (C-7), 163.18 (C-5), 159.37 (C-2), 
158.52 (C-9), 149.79 (C-4’), 146.41 (C-4’), 136.32 (C-
3), 123.10 (C-6’), 123.05 (C-1’), 117.13 (C-5’), 116.51 
(C-2’), 103.58 (C-1’’), 99.95 (C-6), 94.88 (C-8), 73.39 
(C-4’’), 72.24 (C-2’’), 72.10 (C-3’’), 71.99 (C-5’’), and 
17.77 (C-6’’).
FIGURE 3 - HPLC-DAD (λ=254 nm) separation of the ethyl acetate fraction from Kalanchoe pinnata leaves. The separation was 
carried out on a Shimadzu LC-20A series, 250 mm x 4.6 mm, 5 µm Shim-pack VP-ODS C18 reverse-phase column (Shimadzu®), 
at flow rate of 1 mL/min. Isocratic elution (25% acetonitrile and water with 0.1% trifluoroacetic acid) in 15 min.
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The isolated compounds are flavonoids. Flavonoids 
are phenolic substances with many health properties 
that frequently have antioxidant activities as well 
(Benavente-García et al., 1997). Previous studies have 
shown that K. pinnata is an important source of phenolic 
compounds, mainly flavonoids (Costa et al., 2008). 
Many flavonoids have been previously described in this 
species, including the compounds isolated in this study 
(Muzitano et al., 2006a, 2006b; Tatsimo et al., 2012). 
The literature reports that compound 1 (diglycosylated 
flavonoid) showed antiallergic actions (Ichikawa, Ogura, 
Lijima, 1986), high antioxidant potential (Nascimento 
et al., 2013) and antileishmanial activities (Muzitano et 
al., 2006a). Moreover, quercetrin (2) protected skin from 
UVB-induced inflammation (Yin et al., 2013), displayed 
antioxidant (Aderogba, Okoh, Idowu, 2005; Tai et al., 
2014) and antileishmanial activities (Muzitano et al., 
2006b), showed antiproliferative and apoptotic effects 
in colon cancer cells (Cincin et al., 2015), demonstrated 
gastroprotective actions (Mota et al., 2009) and showed 
intestinal anti-inflammatory effects (Camuesco et al., 
2004). Júnior et al., (2014) reported that quercitrin was 
present in Croton campestris extracts at 2.34% and might 
be involved in gastroprotective activities against ethanol, 
acidified ethanol-, and indomethacin-induced gastric 
lesions. This antiulcer effect seems to be mediated by NO 
and endogenous prostaglandin pathways. Quercetin is a 
structure common to both isolated compounds in our lab. 
This molecule could be responsible for antiulcer activity. 
Kahraman et al., (2003) found that the treatment of rats 
with quercetin (200 mg/kg) inhibited ethanol-induced 
gastric lesions and suggested that antiperoxidative and 
antihistaminic effects and antioxidant mechanisms 
mediated this effect. Quercetin was also related to 
gastroprotection in indomethacin-induced gastric damage 
(Shakeerabanu et al., 2011).
In our experiments, the total amount of flavonoid 
and phenolic compounds in the ethyl acetate fraction 
was higher than that in the hydroethanolic extract and 
aqueous fractions (Table I). Because many studies 
revealed a relationship between phenolic compounds and 
antioxidant activity (Popa et al., 2012; Jemia et al., 2013), 
the antioxidant activity was also assessed to determine the 
possible mechanisms of action.
The antioxidant activity of flavonoids plays an 
important role in gastroprotective activities (Alvarez-
Suarez et al., 2011). Studies have demonstrated that 
these compounds can scavenge superoxide, hydroxyl and 
peroxyl radicals. Moreover, they are involved in lipid 
peroxidation inhibition, mucus production, decrease of 
histamine levels and inhibition of gastric acid secretion 
(Priya, Parminder, Jaspreet, 2012; Repetto, Llesuy, 2002). 
Li et al., (2015) reported that the flavonoids from Abrus 
cantoniensis extracted with ethanol had an antiulcer effect, 
probably due to their antioxidant activity.
There are two methods of measuring total antioxidant 
capacity: assays based on hydrogen atom transfer (HAT), 
such as ORAC, and assays based on electron transfer (ET), 
such as DPPH. It is advisable to use two or more different 
methods of antioxidant capacity measurement because of 
the different mechanisms of action of antioxidants (Huang, 
Ou, Prior, 2005). The results of the antioxidant capacity 
FIGURE 4 - Structural formulas of compound 1 quercetin 3-O-α-L-arabinopyranosyl-(1→2)-α-L-rhamnopyranoside and 
compound 2 quercitrin isolated from the Kalanchoe pinnata leaves.
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experiments by DPPH showed that the ethyl acetate 
fraction (CE50 = 41.91 μg/mL) was more active than the 
hydroethanolic extract (CE50=72.63 μg/mL). The CE50 of 
Trolox®, the reference compound, was (CE50=33.38 μg/mL). 
However,  Tatismo et al . ,  (2012) found that  the 
antioxidant activity of the MeOH extract of K. pinnata 
(CE50 = 52.48 μg/mL) was higher than that of the ethyl 
acetate fraction (CE50=78.11 μg/mL). The values obtained 
by the ORAC method for the hydroethanolic extract 
and the ethyl acetate fraction were 4.31 mmol TE/g and 
11.33 mmol TE/g, respectively. The antioxidant capacity 
was higher in the ethyl acetate fraction in both assays 
(DPPH and ORAC).
These data suggest that the gastroprotective effect 
is due, at least partially, to flavonoids and the antioxidant 
capacity of these substances in all samples tested.
CONCLUSION
Our results provide evidence for the popular use 
of Kalanchoe pinnata in treating gastric ulcer. This can 
be confirmed by the gastroprotective potential of K. 
pinnata in the animal model. The ethyl acetate fraction 
reduced gastric lesions by 50% at a dose of 200 mg/kg, 
most likely due to the high amounts of phenolic and 
flavonoid compounds present in this fraction. Studies are 
currently being conducted by our group to investigate the 
mechanisms of action of the flavonoid fraction present in 
this species. 
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